Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: July 2021

MissionIRNewsBreaks – Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Receives Listing Approval from NYSE American

Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, will be moving exchanges. The company has announced that it  received conditional listing approval from the NYSE American LLC stock exchange. The NYSE American is designed for … Continue reading

Posted in Cybin Inc. CLXPF, Cybin Inc. CYBN, MissionIRNewsBreaks | Leave a comment

TAAT Global Alternatives Inc. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP2) Seeing Exceptional Success in Smoking Space

TAAT offers tobacco-free, nicotine-free experience that goes beyond smoking Exclusive product touches all-important five sensory elements of smoking Company is gaining TAAT gaining momentum in the $814 billion tobacco industry” In a world where tobacco and nicotine use both cause … Continue reading

Posted in TAAT Lifestyle & Wellness Ltd. TOBAF | Leave a comment

Ideanomics Inc.’s (NASDAQ: IDEX) Sales To Finance to Charging (S2F2C) Business Model Paves Way For Exponential Growth Opportunities

Ideanomics’s EV market is expected to grow exponentially, driven by growing public awareness/acceptance and the U.S. administration’s support The company plans its expansion moves across three strong EV pillars: vehicles, charging, and energy IDEX acquisition of California-based Solectrac reflects the … Continue reading

Posted in Ideanomics IDEX, | Leave a comment

FingerMotion Inc. (FNGR) Releases Q1 2022 Reports Showing Continuing Upward Growth Trend

FingerMotion (FNGR) a rapidly evolving tech company serving markets in China, announced its financial results for the period Q1 2022 The company generated $6.00 million in revenue, representing the fourth consecutive quarter of record revenue The Telecommunications Products & Services … Continue reading

Posted in FingerMotion Inc. FNGR | Leave a comment

MissionIRNewsBreaks – Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Moving Psychedelic Therapeutics Field Forward Through Partnership

Cybin (NEO: CYBN) (OTCQB: CLXPF), a life sciences company advancing psychedelic therapeutics for various psychiatric and neurological conditions, is sponsoring research to see if psychedelic medicine, when used with EMBARK’s supportive therapy, can help clinicians recover from COVID-related distress. The … Continue reading

Posted in Cybin Inc. CLXPF | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Establishes New Subsidiary, Provides Update on Anticipated Acquisition

Pressure BioSciences (OTCQB: PBIO) has established a wholly owned agrochemicals subsidiary; the subsidiary will be named PBI Agrochem Inc. and is designed to house the announced asset acquisition from Global Agrochemicals Innovator. PBIO previously announced the acquisition of Global Agrochemicals … Continue reading

Posted in Pressure BioSciences Inc. PBIO | Leave a comment

MissionIRNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Demonstrates Significantly Enhanced Delivery of Colchicine

Lexaria Bioscience Corp. (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that its tolerability and pharmacokinetic study VIRAL-A20-3 has been completed with positive results. According to the update, the study demonstrated that DehydraTECH(TM)-enabled colchicine, the latest … Continue reading

Posted in Lexaria Bioscience Corp. LEXX, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) Announces Historically High Productivity Rates for Platosa Mine

Excellon Resources (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) today announced second quarter 2021 production results from the Platosa Mine in Durango, Mexico. Among the highlights, the company reported silver equivalent (“AgEq”) production of 487,009 oz. In addition, Platosa achieved its … Continue reading

Posted in Excellon Resources Inc. EXN, MissionIRNewsBreaks | Leave a comment

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) to Begin Patient Dosing in Berubicin Phase 2 Clinical Trial During Q3 2021, and Received Fast Track Designation from FDA

CNS Pharmaceuticals has been granted FDA Fast Track Designation for Berubicin due to the serious unmet medical need for new GBM treatments Enrollment into the potentially pivotal study for Berubicin and glioblastoma multiforme (“GBM”) in adults is already underway CNS … Continue reading

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment

Keynote Speaker Presentations from SRAX Inc.’s (NASDAQ: SRAX) 2021 Sequire Blockchain Conference Now Available on Demand

2021 Sequire Blockchain Conference presentations now available on demand Conference featured over 15 established and emerging companies across blockchain, cryptocurrency spaces Keynote speakers included Brock Pierce, Maja Vujinovic, Saum Noursalehi, George Stella, Brittany Kaiser SRAX (NASDAQ: SRAX), a leading financial … Continue reading

Posted in SRAX, Inc. SRAX | Leave a comment